N/A
N=541
Brain and Genetic Predictors of Individual Differences in Pain and Analgesia
Pain, Acute
Bottom Line
View on ClinicalTrials.gov: NCT03781570 ↗Enrolled (actual)
541
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Pain Rating Scores Made on a Visual Analog Scale (VAS) — 0.136; 0.190; 0.126; 0.160 Score on a scale — p=<0.001
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Placebo Cream (Behavioral); Control Cream (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Trustees of Dartmouth College
- Primary completion
- Oct 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Rating Scores Made on a Visual Analog Scale (VAS) |
0.136; 0.190; 0.126; 0.160 | <0.001 sig |
Summary
The purpose of the study is to gain a better understanding of pain processing in the brain. Our understanding of how pain is processed in the brain is limited. We are testing for individual differences in pain perception and emotion.
Eligibility Criteria
Inclusion Criteria
- Participants must be registered in the Colorado Community Twin Sample (CTS).
Exclusion Criteria
- Not being registered in the Colorado Community Twin Sample (CTS).
- Any MRI contraindications.
Data sourced from ClinicalTrials.gov (NCT03781570). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.